Dr. F. Dan Atkins answers the question: 'What Are Common Causes Of Anaphylaxis?' — -- Question: What are common causes of anaphylaxis? Answer: The common causes of anaphylaxis are foods, ...

Please provide your email address to receive an email when new articles are posted on . 44% of patients using LLM had severe anaphylaxis. This was the first study to show an association between LLM ...

The FDA has added a boxed warning, its most serious designation, to Copaxone and Glatopa due to the risk of anaphylaxis, a rare but serious allergic reaction. This severe reaction can occur at any ...

The US Food and Drug Administration (FDA) has added a boxed warning to the label of multiple sclerosis drug glatiramer acetate about the risk of anaphylaxis. From December 1996 through May 2024, 82 ...

The FDA has delayed approval of Aquestive Therapeutics’ new drug application seeking approval of Anaphylm, a sublingual epinephrine film for the treatment of Type 1 allergic reactions, including ...

New research in mice has shown that food-induced anaphylaxis is driven by distinct immune pathways involving inflammatory lipids called leukotrienes. The findings, published across two separate ...

Please provide your email address to receive an email when new articles are posted on . Patients with active asthma symptoms were 14.43 times more likely to be admitted to the PICU. Patients admitted ...

The FDA added a boxed warning about rare cases of anaphylaxis associated with the multiple sclerosis (MS) drug glatiramer acetate (Copaxone, Glatopa), the agency announced on Wednesday. The warning ...

The Food and Drug Administration has approved ARS Pharmaceutical’s Neffy (epinephrine nasal spray) for the emergency treatment of allergic reactions (type I), including those that are life-threatening ...

Most of the patients in these reported cases experienced anaphylaxis within 1 hour after injection. Reports of anaphylaxis associated with the use of glatiramer acetate have prompted the Food and Drug ...

ARS Pharma had high hopes that the FDA on Tuesday would approve its flagship product, a needle-free treatment for adults and children with severe allergic reactions. But instead, the drugmaker was set ...

One in 10 people live with the fear of accidental exposures to things like peanuts, eggs or milk. An EpiPen is always at their side. Now, a Chicago research team says a drug already on the market ...